JMS PHARMA LTD, BELFAST, Reino Unido

Acionistas

Nome	Participação	Voto	Desde

Beneficiário efetivo

Nome	Participação	País	Desde

Finanças

Indicadores das demonstrações anuais.

Converter para

2012

Lucro / (prejuízo): £555

Indicadores

Lucro / (prejuízo)

2012£555

2013£-1.544

2014£2.198

2015£8

2016£413

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Ativo total

2012£1.555

2013£-544

2014£3.198

2015£1.008

2016£1.413

2017£1.115

2018£1.115

2019£1.115

2020£2.098

2021£0

2022£1.375

2023£1.062

2024£12.629

2025£1.095

Net Assets Liabilities

2012—

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021£0

2022£1.375

2023£1.062

2024£12.629

2025£1.095

Equity

2012—

2013—

2014—

2015—

2016—

2017—

2018—

2019£1.115

2020£2.098

2021£0

2022£1.375

2023£1.062

2024£12.629

2025£1.095

Current Assets

2012£15.506

2013£15.246

2014£24.786

2015£13.502

2016£13.047

2017£11.119

2018£13.801

2019£13.801

2020£13.041

2021£14.109

2022£44.909

2023£27.134

2024£30.863

2025£4.582

Net Current Assets Liabilities

2012£627

2013£15.246

2014£1.273

2015£-1.858

2016£-5.604

2017£-4.744

2018£-2.314

2019£-3.448

2020£-2.392

2021£-4.155

2022£21.202

2023£8.717

2024£11.014

2025£-14.001

Total Assets Less Current Liabilities

2012£1.555

2013£16.914

2014£3.198

2015£1.008

2016£1.413

2017£2.160

2018£2.249

2019£1.115

2020£2.098

2021£0

2022£23.875

2023£11.668

2024£18.678

2025£2.862

Debtors

2012£9.407

2013£10.162

2014£1.848

2015£12.596

2016£1.483

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Creditors

2012—

2013—

2014—

2015—

2016—

2017—

2018—

2019£17.249

2020£15.433

2021£0

2022£22.500

2023£10.606

2024£6.049

2025£1.767

Average Number Employees During Period

2012—

2013—

2014—

2015—

2016—

2017—

2018—

20191

20201

20212

20222

20233

20243

20252

Accruals Deferred Income

2012—

2013—

2014—

2015—

2016—

2017£1.045

2018£1.134

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Called Up Share Capital

2012£1.000

2013£1.000

2014£1.000

2015£1.000

2016£1.000

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Cash Bank In Hand

2012£6.099

2013£5.084

2014£22.938

2015£906

2016£6.565

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Creditors Due After One Year

2012—

2013£17.458

2014£23.513

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Creditors Due After One Year Total Noncurrent Liabilities

2012£14.879

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Creditors Due Within One Year

2012£14.879

2013£22.394

2014£23.513

2015£15.360

2016£18.651

2017£15.863

2018£16.115

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Creditors Due Within One Year Total Current Liabilities

2012£-6.099

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Fixed Assets

2012£928

2013£1.668

2014£1.925

2015£2.866

2016£7.017

2017£6.904

2018£4.563

2019£4.563

2020£4.490

2021£4.155

2022£2.673

2023£2.951

2024£7.664

2025£16.863

Net Assets Liabilities Including Pension Asset Liability

2012£1.555

2013£-544

2014£3.198

2015£1.008

2016£1.413

2017£1.115

2018£1.115

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Profit Loss Account Reserve

2012£555

2013£-1.544

2014£2.198

2015£8

2016£413

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Shareholder Funds

2012£1.555

2013£-544

2014£3.198

2015£1.008

2016£1.413

2017£1.115

2018£1.115

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Stocks Inventory

2012—

2013—

2014—

2015£0

2016£5.000

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets

2012£928

2013£1.668

2014£1.925

2015£2.866

2016£7.016

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets Additions

2012£966

2013£1.581

2014£569

2015£1.392

2016£7.638

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets Cost Or Valuation

2012£966

2013£2.546

2014£3.115

2015£4.507

2016£12.145

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets Depreciation

2012£38

2013£878

2014£1.190

2015£1.641

2016£5.129

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets Depreciation Charged In Period

2012—

2013£840

2014£312

2015£451

2016£3.488

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Tangible Fixed Assets Depreciation Charge For Period

2012£38

2013—

2014—

2015—

2016—

2017—

2018—

2019—

2020—

2021—

2022—

2023—

2024—

2025—

Métrica	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Lucro / (prejuízo)	£555	£-1.544	£2.198	£8	£413	—	—	—	—	—	—	—	—	—
Ativo total	£1.555	£-544	£3.198	£1.008	£1.413	£1.115	£1.115	£1.115	£2.098	£0	£1.375	£1.062	£12.629	£1.095
Net Assets Liabilities	—	—	—	—	—	—	—	—	—	£0	£1.375	£1.062	£12.629	£1.095
Equity	—	—	—	—	—	—	—	£1.115	£2.098	£0	£1.375	£1.062	£12.629	£1.095
Current Assets	£15.506	£15.246	£24.786	£13.502	£13.047	£11.119	£13.801	£13.801	£13.041	£14.109	£44.909	£27.134	£30.863	£4.582
Net Current Assets Liabilities	£627	£15.246	£1.273	£-1.858	£-5.604	£-4.744	£-2.314	£-3.448	£-2.392	£-4.155	£21.202	£8.717	£11.014	£-14.001
Total Assets Less Current Liabilities	£1.555	£16.914	£3.198	£1.008	£1.413	£2.160	£2.249	£1.115	£2.098	£0	£23.875	£11.668	£18.678	£2.862
Debtors	£9.407	£10.162	£1.848	£12.596	£1.483	—	—	—	—	—	—	—	—	—
Creditors	—	—	—	—	—	—	—	£17.249	£15.433	£0	£22.500	£10.606	£6.049	£1.767
Average Number Employees During Period	—	—	—	—	—	—	—	1	1	2	2	3	3	2
Accruals Deferred Income	—	—	—	—	—	£1.045	£1.134	—	—	—	—	—	—	—
Called Up Share Capital	£1.000	£1.000	£1.000	£1.000	£1.000	—	—	—	—	—	—	—	—	—
Cash Bank In Hand	£6.099	£5.084	£22.938	£906	£6.565	—	—	—	—	—	—	—	—	—
Creditors Due After One Year	—	£17.458	£23.513	—	—	—	—	—	—	—	—	—	—	—
Creditors Due After One Year Total Noncurrent Liabilities	£14.879	—	—	—	—	—	—	—	—	—	—	—	—	—
Creditors Due Within One Year	£14.879	£22.394	£23.513	£15.360	£18.651	£15.863	£16.115	—	—	—	—	—	—	—
Creditors Due Within One Year Total Current Liabilities	£-6.099	—	—	—	—	—	—	—	—	—	—	—	—	—
Fixed Assets	£928	£1.668	£1.925	£2.866	£7.017	£6.904	£4.563	£4.563	£4.490	£4.155	£2.673	£2.951	£7.664	£16.863
Net Assets Liabilities Including Pension Asset Liability	£1.555	£-544	£3.198	£1.008	£1.413	£1.115	£1.115	—	—	—	—	—	—	—
Profit Loss Account Reserve	£555	£-1.544	£2.198	£8	£413	—	—	—	—	—	—	—	—	—
Shareholder Funds	£1.555	£-544	£3.198	£1.008	£1.413	£1.115	£1.115	—	—	—	—	—	—	—
Stocks Inventory	—	—	—	£0	£5.000	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets	£928	£1.668	£1.925	£2.866	£7.016	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets Additions	£966	£1.581	£569	£1.392	£7.638	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets Cost Or Valuation	£966	£2.546	£3.115	£4.507	£12.145	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets Depreciation	£38	£878	£1.190	£1.641	£5.129	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets Depreciation Charged In Period	—	£840	£312	£451	£3.488	—	—	—	—	—	—	—	—	—
Tangible Fixed Assets Depreciation Charge For Period	£38	—	—	—	—	—	—	—	—	—	—	—	—	—

JMS PHARMA LTD

Resumo

Legal e status

Linha do tempo (17 eventos)

Endereço atualizado

Endereço atualizado

Empresa constituída

Rede

Propriedade e gestão

Persons with significant control

Linha do tempo de propriedade (2 alterações)

Nomeação James Storey (pessoa)

Nomeação Judith Storey (pessoa)

Acionistas

Beneficiário efetivo

Geografia

Finanças

Indicadores

Documentos

Relatório da empresa JMS PHARMA LTD

Annual Accounts

Companexia Document AI

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Annual Accounts

Explorar mais empresas e pessoas

Saúde financeira

Crescimento

Eficiência e rentabilidade

Capital circulante e liquidez

Estrutura de capital